Trident Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-12-2024
- Paid Up Capital ₹ 0.82 M
as on 15-12-2024
- Company Age 36 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 13.77 Cr
as on 15-12-2024
- Revenue -22.33%
(FY 2017)
- Profit -6.43%
(FY 2017)
- Ebitda -67.51%
(FY 2017)
- Net Worth 1.76%
(FY 2017)
- Total Assets -17.44%
(FY 2017)
About Trident Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.82 M.
The company has closed loans amounting to ₹13.77 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Birudavolu Reddy and Damodar Adala serve as directors at the Company.
- CIN/LLPIN
U24230TG1988PTC009153
- Company No.
009153
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Trident Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Damodar Adala  | Director | 06-Dec-2017 | Current |
| Birudavolu Reddy | Director | 02-Jan-1989 | Current |
Financial Performance and Corporate Structure Insights of Trident Laboratories.
Trident Laboratories Pvt Ltd., for the financial year ended 2017, experienced significant reduction in revenue, with a 22.33% decrease. The company also saw a slight decrease in profitability, with a 6.43% decrease in profit. The company's net worth moved up by a moderate rise of 1.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trident Laboratories?
In 2017, Trident Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vishwa Infrastructures And Services Private LimitedActive 20 years 9 daysBirudavolu Reddy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Global Trust Bank Creation Date: 15 Nov 1996 | ₹10.70 Cr | Satisfied |
Bank Of Baroda Creation Date: 31 Mar 1993 | ₹3.07 Cr | Satisfied |
How Many Employees Work at Trident Laboratories?
Unlock and access historical data on people associated with Trident Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trident Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trident Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
